NAS:OFIX (N/A) Also trade in: Germany

Orthofix Medical Inc

$ 51.22 -0.09 (-0.18%)
On watch
Volume: 68,268 Avg Vol (1m): 137,714
Market Cap $: 976.62 Mil Enterprise Value $: 951.19 Mil
P/E (TTM): 104.51 P/B: 2.88
Earnings Power Value 5.16
Net Current Asset Value 4.62
Tangible Book 11.24
Projected FCF 28.23
Median P/S Value 38.13
Graham Number 11.13
Peter Lynch Value 12.25
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 8/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 2.20
Cash-To-Debt ranked higher than
97.27% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
OFIX: 2.2
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.02, Med: 1.54, Max: 10000
Current: 2.2
0.02
10000
Equity-to-Asset 0.72
Equity-to-Asset ranked higher than
67.31% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
OFIX: 0.72
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.36, Med: 0.71, Max: 0.85
Current: 0.72
0.36
0.85
Debt-to-Equity 0.06
Debt-to-Equity ranked lower than
100.00% of 220 companies
in the Medical Devices industry.
Industry Max: 11.69, Med: 0.3, Min: 0.01
OFIX: 0.06
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.16, Max: 1.42
Current: 0.06
0
1.42
Debt-to-EBITDA 0.55
Debt-to-EBITDA ranked lower than
100.00% of 158 companies
in the Medical Devices industry.
Industry Max: 3384.46, Med: 1.98, Min: 0.02
OFIX: 0.55
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 0.21, Med: 2.42, Max: 2.92
Current: 0.55
0.21
2.92
Interest Coverage 28.09
Interest Coverage ranked higher than
52.36% of 212 companies
in the Medical Devices industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
OFIX: 28.09
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 2.57, Med: 13.95, Max: 10000
Current: 28.09
2.57
10000
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.06
DISTRESS
GREY
SAFE
Beneish M-Score -2.47
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 12.27%
WACC 5.58%

Profitability & Growth : 6/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 5.59
Operating Margin ranked higher than
67.31% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
OFIX: 5.59
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 2.01, Med: 8.03, Max: 17.3
Current: 5.59
2.01
17.3
Net Margin % 2.09
Net Margin ranked higher than
50.32% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
OFIX: 2.09
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -7.25, Med: 1.09, Max: 9.73
Current: 2.09
-7.25
9.73
ROE % 2.90
ROE ranked higher than
53.62% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
OFIX: 2.9
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -8.83, Med: 1.66, Max: 16.37
Current: 2.9
-8.83
16.37
ROA % 2.11
ROA ranked higher than
56.33% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
OFIX: 2.11
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -6.57, Med: 1.2, Max: 7.45
Current: 2.11
-6.57
7.45
ROC (Joel Greenblatt) % 11.48
ROC (Joel Greenblatt) ranked higher than
76.76% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
OFIX: 11.48
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 3.35, Med: 21.95, Max: 31.8
Current: 11.48
3.35
31.8
3-Year Total Revenue Growth Rate 4.50
3-Year Revenue Growth Rate ranked lower than
55.12% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
OFIX: 4.3
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -10.5, Med: 12.2, Max: 28.7
Current: 4.3
-10.5
28.7
3-Year Total EBITDA Growth Rate 7.50
3-Year EBITDA Growth Rate ranked higher than
61.64% of 232 companies
in the Medical Devices industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
OFIX: 7.3
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 3.6, Max: 47
Current: 7.3
0
47

» OFIX's 30-Y Financials

Financials (Next Earnings Date: 2019-08-06)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:OFIX

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 339112    SIC : 3841
Compare TSE:6960 NAS:XENT OSTO:ARJO B SZSE:300298 SHSE:603387 NYSE:CRY SZSE:300326 NAS:TCMD NAS:BABY NYSE:INSP NAS:SWAV XTER:DRW3 SZSE:002317 HKSE:01302 NAS:SILK SHSE:600587 NAS:AXGN NAS:CSII XTER:SBS TSE:7575
Traded in other countries OM2.Germany
Address 3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix International NV is a medical device company that provides reconstructive and regenerative orthopedic and spine solutions to physicians. The firm operates in four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim business generates the largest proportion of revenue and sells devices that enhance bone fusion. The Biologics business markets a portfolio of regenerative products and tissue forms used by physicians to treat spinal and orthopedic conditions. The Extremity Fixation unit sells products used for fracture repair and bone reconstruction procedures. The Spine Fixation unit sells implant products used in spine surgery. Orthofix generates the vast majority of its revenue in the United States.

Ratios

Current vs industry vs history
PE Ratio (TTM) 104.51
PE Ratio ranked lower than
95.00% of 180 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
OFIX: 104.51
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 10.36, Med: 63.1, Max: 1182.5
Current: 104.51
10.36
1182.5
Forward PE Ratio 28.57
Forward P/E ranked lower than
73.08% of 52 companies
in the Medical Devices industry.
Industry Max: 454.55, Med: 25.06, Min: 3.33
OFIX: 28.57
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 104.51
PE without NRI ranked lower than
94.97% of 179 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
OFIX: 104.51
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 10.36, Med: 63.1, Max: 2668.5
Current: 104.51
10.36
2668.5
PB Ratio 2.88
PB Ratio ranked lower than
59.03% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
OFIX: 2.88
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.77, Med: 2.16, Max: 3.72
Current: 2.88
0.77
3.72
PS Ratio 2.12
PS Ratio ranked higher than
60.88% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
OFIX: 2.12
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.31, Med: 1.59, Max: 2.72
Current: 2.12
0.31
2.72
Price-to-Free-Cash-Flow 26.93
Price-to-Free-Cash-Flow ranked lower than
54.21% of 107 companies
in the Medical Devices industry.
Industry Max: 3239, Med: 26.44, Min: 5.07
OFIX: 26.93
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 9.76, Med: 24.13, Max: 80.14
Current: 26.93
9.76
80.14
Price-to-Operating-Cash-Flow 18.41
Price-to-Operating-Cash-Flow ranked lower than
55.12% of 127 companies
in the Medical Devices industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
OFIX: 18.41
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 5.73, Med: 12.87, Max: 64.4
Current: 18.41
5.73
64.4
EV-to-EBIT 51.47
EV-to-EBIT ranked higher than
50.00% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
OFIX: 51.47
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -2.7, Med: 22.8, Max: 473.7
Current: 51.47
-2.7
473.7
EV-to-EBITDA 24.72
EV-to-EBITDA ranked higher than
54.26% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
OFIX: 24.72
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -3, Med: 14.85, Max: 122.9
Current: 24.72
-3
122.9
EV-to-Revenue 2.10
EV-to-Revenue ranked higher than
64.72% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
OFIX: 2.1
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.9, Med: 1.6, Max: 2.6
Current: 2.1
0.9
2.6
PEG Ratio 9.87
PEG Ratio ranked lower than
96.10% of 77 companies
in the Medical Devices industry.
Industry Max: 804, Med: 2.53, Min: 0.14
OFIX: 9.87
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 1.64, Med: 4.83, Max: 9.87
Current: 9.87
1.64
9.87
Shiller PE Ratio 116.01
Shiller PE Ratio ranked lower than
100.00% of 58 companies
in the Medical Devices industry.
Industry Max: 636.22, Med: 49.95, Min: 2.03
OFIX: 116.01
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 10.38, Med: 125.11, Max: 942.67
Current: 116.01
10.38
942.67
Current Ratio 3.52
Current Ratio ranked higher than
56.79% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
OFIX: 3.52
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.56, Med: 3.4, Max: 5.15
Current: 3.52
1.56
5.15
Quick Ratio 2.28
Quick Ratio ranked higher than
53.40% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
OFIX: 2.28
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 1.13, Med: 2.55, Max: 4.2
Current: 2.28
1.13
4.2
Days Inventory 299.99
Days Inventory ranked lower than
80.95% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
OFIX: 299.99
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 243.23, Med: 262.69, Max: 336.86
Current: 299.99
243.23
336.86
Days Sales Outstanding 64.09
Days Sales Outstanding ranked higher than
75.72% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
OFIX: 64.09
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 51.53, Med: 63.82, Max: 105.88
Current: 64.09
51.53
105.88
Days Payable 74.54
Days Payable ranked higher than
58.24% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
OFIX: 74.54
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 48.79, Med: 69.08, Max: 81.8
Current: 74.54
48.79
81.8

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -0.40
3-Year Share Buyback Rate ranked higher than
90.57% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
OFIX: -0.4
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -8.6, Med: -1.5, Max: 1.2
Current: -0.4
-8.6
1.2

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 4.56
Price-to-Tangible-Book ranked lower than
51.45% of 276 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 4.5, Min: 0.07
OFIX: 4.56
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 1.48, Med: 4.3, Max: 110.32
Current: 4.56
1.48
110.32
Price-to-Projected-FCF 1.81
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
56.20% of 121 companies
in the Medical Devices industry.
Industry Max: 89.64, Med: 2.44, Min: 0.43
OFIX: 1.81
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.55, Med: 1.48, Max: 23.25
Current: 1.81
0.55
23.25
Price-to-Median-PS-Value 1.34
Price-to-Median-PS-Value ranked lower than
79.32% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
OFIX: 1.34
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.32, Med: 1.22, Max: 2.9
Current: 1.34
0.32
2.9
Price-to-Peter-Lynch-Fair-Value 4.18
Price-to-Peter-Lynch-Fair-Value ranked lower than
100.00% of 47 companies
in the Medical Devices industry.
Industry Max: 26.18, Med: 2.05, Min: 0.43
OFIX: 4.18
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.23, Med: 1.03, Max: 7.91
Current: 4.18
0.23
7.91
Price-to-Graham-Number 4.60
Price-to-Graham-Number ranked lower than
83.46% of 133 companies
in the Medical Devices industry.
Industry Max: 59.6, Med: 2.11, Min: 0.06
OFIX: 4.6
Ranked among companies with meaningful Price-to-Graham-Number only.
Price-to-Graham-Number range over the past 10 years
Min: 0.88, Med: 2.04, Max: 20.29
Current: 4.6
0.88
20.29
Earnings Yield (Joel Greenblatt) % 1.95
Earnings Yield (Greenblatt) ranked higher than
74.10% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
OFIX: 1.95
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -61.2, Med: 3.75, Max: 15.2
Current: 1.95
-61.2
15.2
Forward Rate of Return (Yacktman) % 22.73
Forward Rate of Return ranked lower than
63.20% of 125 companies
in the Medical Devices industry.
Industry Max: 78.28, Med: 6.6, Min: -76.71
OFIX: 22.73
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: -41.7, Med: 2.6, Max: 23.2
Current: 22.73
-41.7
23.2

More Statistics

Revenue (TTM) (Mil) $ 453.45
EPS (TTM) $ 0.49
Beta 0.53
Volatility % 29.44
52-Week Range $ 47.79 - 74.44
Shares Outstanding (Mil) 19.07

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N